Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population
Silvia Cantara(University of Siena), Furio Pacini, Guido Sebastiani(University of Siena), Tania Pilli(University of Siena), Giulia Busonero(University of Siena), Sandro Cardinale(University of Siena), Francesco Dotta(University of Siena), Gabriele Cevenini(University of Siena)
Cited by 56
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
|Diabetes Care|2017|574
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
|The Journal of Clinical Endocrinology & Metabolism|2010|316